check_circleStudy Completed

Acne vulgaris, Contraception

Valette low: Bioavailability

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

45 - 75 Years
  • -

  • -

Trial summary

Enrollment Goal
18
Trial Dates
June 2007 - September 2007
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Valette (Dienogest/EE30, BAY86-5038)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Bayer Pharma AGBerlin, 13353, Germany

Trial design

Open-label, randomized, control balanced block study to evaluate the relative bioavailability from four dienogest and ethinylestradiol containing immediate and modified release formulations after single oral administration in 18 healthy postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A